Previous Section
General Interest Articles
29. Does body mass index affect outcome after reconstruction of orthotopic neobladder?
- Author
- Reyes MA; Nieder AM; Kava BR; Soloway MS; Manoharan M;
- Institution
- Department of Urology, University of Miami Miller School of Medicine, Miami, Florida 33101, USA.
- Journal
- Urology. 2007 Mar;69(3):475-8.
- Abstract URL
- Click here to view abstract
30. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma.
- Author
- Sharma P; Shen Y; Wen S; Yamada S; Jungbluth AA; Gnjatic S; Bajorin DF; Reuter VE; Herr H; Old LJ; Sato E;
- Institution
- Department of Genitourinary Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. padsharma@mdanderson.org
- Journal
- Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3967-72. Epub 2007 Feb 27.
- Abstract URL
- Click here to view abstract
31. Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.
- Author
- Higano CS; Tangen CM; Sakr WA; Faulkner J; Rivkin SE; Meyers FJ; Hussain M; Baker LH; Russell KJ; Crawford ED;
- Institution
- Department of Medicine, Division of Oncology, University of Washington, Seattle, Washington, USA.
- Journal
- Cancer. 2008 May 15;112(10):2181-7.
- Abstract URL
- Click here to view abstract
32. Review of the M.D. Anderson experience in the treatment of bladder sarcoma.
- Author
- Spiess PE; Kassouf W; Steinberg JR; Tuziak T; Hernandez M; Tibbs RF; Czerniak B; Kamat AM; Dinney CP; Grossman HB;
- Institution
- Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4095, USA.
- Journal
- Urol Oncol. 2007 Jan-Feb;25(1):38-45.
- Abstract URL
- Click here to view abstract
Next: Drug Therapy
